SENNA- sennosides tablet 
Chain Drug Consortium, LLC (Premier Value)

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

DRUG FACTS

Active Ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

Warnings
Do not use

Ask a doctor before using if

you have

  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel movements that continues over a period of 2 weeks.

Stop use and ask a doctor if

  • you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

 age

 starting dosage  maximum dosage
 adults and children 12 years of age or older  2 tablets once a day  4 tablets twice a day
 children 6 to under 12 years  1 tablet once a day  2 tablets twice a day
 children 2 to under 6 years  1/2 tablet once a day  1 tablet twice a day
 children under 2 years  ask a doctor  ask a doctor


Other information


Inactive Ingredients

croscarmellose sodium, dibasic calcium phosphate dihydrate, dicalcium phosphate*, hypromellose, magnesium stearate, maltodextrin*, microcrystalline cellulose, mineral oil, polyethylene glycol*, purified water*, silicon dioxide*, stearic acid*, talc*, and triacetin*

*contains one or more of these ingredients

Questions or comments?

call toll free: 1-877-753-3935 Monday- Friday 9AM- 5PM EST

Principal Display Panel

**Compare to the active ingredient in senokot®

Senna

Sennosides 8.6 mg

Standardized senna concentrate

Natural vegetable laxative

Relieves occasional constipation

Distributed by:

CHAIN DRUG CONSORTIUM, LLC

3301 NW BOCA RATON BLVD. SUITE 101

BOCA RATON, FL 33431

KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION

Product Labeling

Premier Value Senna 8.6 mg

Sennosides 8.6 mg

SENNA 
sennosides tablet
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:68016-117
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES 8.6 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
MINERAL OIL (UNII: T5L8T28FGP)  
POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
WATER (UNII: 059QF0KO0R)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
TALC (UNII: 7SEV7J4R1U)  
TRIACETIN (UNII: XHX3C3X673)  
Product Characteristics
Color BROWN (BROWN) Score no score
Shape ROUND (ROUND) Size 9mm
Flavor Imprint Code S3;TLC080;S8
Contains     
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:68016-117-00 1 in 1 BOX
1 100 in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC MONOGRAPH NOT FINAL part334 04/18/2011
Labeler - Chain Drug Consortium, LLC (Premier Value) (101668460)

Revised: 10/2012
Document Id: 7048935f-40c4-4c9e-96e3-793453c8420d
Set id: 3f43ff4b-c6e5-42a6-b2da-dc5e862f2c76
Version: 2
Effective Time: 20121003
 
Chain Drug Consortium, LLC (Premier Value)